This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Thomas Jefferson University. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Innovations by Alexey Laptev in Medical Treatments
Introduction
Alexey Laptev is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical treatments, particularly in the area of stromal cell therapy. His innovative work focuses on methods for treating patients suffering from various diseases, disorders, or conditions characterized by bone cartilage or lung defects.
Latest Patents
Alexey Laptev holds a patent for "Isolated stromal cells and methods of using the same." This patent outlines methods for treating patients through the intravenous administration of stromal cells isolated from normal syngeneic individuals or from the patients themselves after correcting genetic defects in the isolated cells. The patent also describes implant devices that contain stromal cells isolated from bone marrow, which include a gene construct that encodes a beneficial protein linked to regulatory elements functioning in stromal cells. These methods aim to treat individuals with diseases characterized by gene defects by introducing stromal cells that are physically isolated from the recipient's immune system.
Career Highlights
Alexey Laptev is affiliated with Thomas Jefferson University, where he continues to advance his research and innovations in medical treatments. His work has the potential to significantly impact the treatment of various conditions, enhancing patient outcomes through innovative therapies.
Collaborations
He has collaborated with notable colleagues, including Dennis B Leeper and Michael D O'Hara, contributing to the advancement of research in his field.
Conclusion
Alexey Laptev's contributions to medical science through his patent on stromal cell therapy exemplify the importance of innovation in treating complex health issues. His work continues to pave the way for new therapeutic approaches that can improve the lives of many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
